Annual total expenses:
$1.43B+$286.70M(+25.09%)Summary
- As of today (May 18, 2025), UTHR annual total expenses is $1.43 billion, with the most recent change of +$286.70 million (+25.09%) on December 31, 2024.
- During the last 3 years, UTHR annual total expenses has risen by +$299.70 million (+26.53%).
- UTHR annual total expenses is now -12.66% below its all-time high of $1.64 billion, reached on December 31, 2019.
Performance
UTHR Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$411.60M+$39.40M(+10.59%)Summary
- As of today (May 18, 2025), UTHR quarterly total expenses is $411.60 million, with the most recent change of +$39.40 million (+10.59%) on March 31, 2025.
- Over the past year, UTHR quarterly total expenses has increased by +$90.20 million (+28.06%).
- UTHR quarterly total expenses is now -59.59% below its all-time high of $1.02 billion, reached on March 31, 2019.
Performance
UTHR Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
UTHR Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +28.1% |
| 3 y3 years | +26.5% | +136.7% |
| 5 y5 years | -12.7% | +117.1% |
UTHR Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.4% | at high | +136.7% |
| 5 y | 5-year | -12.7% | +60.6% | -7.3% | +158.9% |
| alltime | all time | -12.7% | >+9999.0% | -59.6% | >+9999.0% |
UTHR Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $411.60M(+10.6%) |
| Dec 2024 | $1.43B(+25.1%) | $372.20M(+9.2%) |
| Sep 2024 | - | $340.70M(-13.7%) |
| Jun 2024 | - | $395.00M(+22.9%) |
| Mar 2024 | - | $321.40M(-9.4%) |
| Dec 2023 | $1.14B(+19.4%) | $354.60M(+25.6%) |
| Sep 2023 | - | $282.40M(-0.2%) |
| Jun 2023 | - | $283.10M(+27.2%) |
| Mar 2023 | - | $222.50M(-29.6%) |
| Dec 2022 | $956.60M(-15.3%) | $315.90M(+56.6%) |
| Sep 2022 | - | $201.70M(-23.9%) |
| Jun 2022 | - | $265.10M(+52.4%) |
| Mar 2022 | - | $173.90M(-29.1%) |
| Dec 2021 | $1.13B(+27.0%) | $245.40M(+13.6%) |
| Sep 2021 | - | $216.00M(-3.7%) |
| Jun 2021 | - | $224.30M(-49.5%) |
| Mar 2021 | - | $443.90M(+38.9%) |
| Dec 2020 | $889.70M(-45.6%) | $319.60M(+101.0%) |
| Sep 2020 | - | $159.00M(-28.2%) |
| Jun 2020 | - | $221.50M(+16.8%) |
| Mar 2020 | - | $189.60M(-23.4%) |
| Dec 2019 | $1.64B(+99.0%) | $247.60M(+13.5%) |
| Sep 2019 | - | $218.10M(+43.3%) |
| Jun 2019 | - | $152.20M(-85.1%) |
| Mar 2019 | - | $1.02B(+307.6%) |
| Dec 2018 | $822.40M(+17.4%) | $249.90M(-5.0%) |
| Sep 2018 | - | $263.10M(+15.9%) |
| Jun 2018 | - | $227.10M(+175.9%) |
| Mar 2018 | - | $82.30M(-74.7%) |
| Dec 2017 | $700.40M(+30.4%) | $325.70M(+167.6%) |
| Sep 2017 | - | $121.70M(-16.7%) |
| Jun 2017 | - | $146.10M(+36.7%) |
| Mar 2017 | - | $106.90M(-54.5%) |
| Dec 2016 | $537.10M(-30.0%) | $234.80M(+38.4%) |
| Sep 2016 | - | $169.60M(+33.1%) |
| Jun 2016 | - | $127.40M(+2303.8%) |
| Mar 2016 | - | $5.30M(-97.9%) |
| Dec 2015 | $766.80M(+2.3%) | $249.90M(<-9900.0%) |
| Sep 2015 | - | -$800.00K(-100.5%) |
| Jun 2015 | - | $175.40M(-48.8%) |
| Mar 2015 | - | $342.30M(+104.0%) |
| Dec 2014 | $749.70M(-9.1%) | $167.77M(-53.7%) |
| Sep 2014 | - | $362.19M(+147.3%) |
| Jun 2014 | - | $146.48M(+99.9%) |
| Mar 2014 | - | $73.26M(-76.9%) |
| Dec 2013 | $824.49M(+66.8%) | $317.51M(+60.7%) |
| Sep 2013 | - | $197.58M(+24.8%) |
| Jun 2013 | - | $158.30M(+4.8%) |
| Mar 2013 | - | $151.10M(+31.1%) |
| Dec 2012 | $494.43M(+16.2%) | $115.21M(-28.8%) |
| Sep 2012 | - | $161.75M(+34.8%) |
| Jun 2012 | - | $119.99M(+23.1%) |
| Mar 2012 | - | $97.48M(-26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $425.40M(+0.9%) | $131.67M(+33.3%) |
| Sep 2011 | - | $98.77M(+42.6%) |
| Jun 2011 | - | $69.26M(-44.9%) |
| Mar 2011 | - | $125.71M(-15.3%) |
| Dec 2010 | $421.59M(+22.6%) | $148.36M(+39.8%) |
| Sep 2010 | - | $106.08M(+82.1%) |
| Jun 2010 | - | $58.24M(-39.7%) |
| Mar 2010 | - | $96.63M(-13.0%) |
| Dec 2009 | $343.85M(-5.4%) | $111.11M(+30.0%) |
| Sep 2009 | - | $85.48M(-3.0%) |
| Jun 2009 | - | $88.10M(+48.9%) |
| Mar 2009 | - | $59.16M(-71.8%) |
| Dec 2008 | $363.55M(+77.7%) | $209.72M(+268.1%) |
| Sep 2008 | - | $56.97M(+14.9%) |
| Jun 2008 | - | $49.57M(+4.8%) |
| Mar 2008 | - | $47.29M(-30.7%) |
| Dec 2007 | $204.64M(+56.6%) | $68.29M(+52.1%) |
| Sep 2007 | - | $44.89M(+2.5%) |
| Jun 2007 | - | $43.79M(-8.2%) |
| Mar 2007 | - | $47.67M(+12.8%) |
| Dec 2006 | $130.65M(+78.9%) | $42.28M(+46.0%) |
| Sep 2006 | - | $28.96M(+0.8%) |
| Jun 2006 | - | $28.73M(-6.4%) |
| Mar 2006 | - | $30.68M(+59.1%) |
| Dec 2005 | $73.02M(+20.9%) | $19.29M(+4.4%) |
| Sep 2005 | - | $18.48M(-2.2%) |
| Jun 2005 | - | $18.89M(+15.4%) |
| Mar 2005 | - | $16.37M(+7.0%) |
| Dec 2004 | $60.38M(-6.9%) | $15.30M(+7.0%) |
| Sep 2004 | - | $14.30M(-2.9%) |
| Jun 2004 | - | $14.73M(-8.3%) |
| Mar 2004 | - | $16.06M(-6.2%) |
| Dec 2003 | $64.87M(+34.8%) | $17.11M(+2.0%) |
| Sep 2003 | - | $16.78M(-0.2%) |
| Jun 2003 | - | $16.80M(+18.6%) |
| Mar 2003 | - | $14.17M(-6.4%) |
| Dec 2002 | $48.12M(-8.6%) | $15.13M(+29.7%) |
| Sep 2002 | - | $11.66M(-9.9%) |
| Jun 2002 | - | $12.94M(+54.4%) |
| Mar 2002 | - | $8.38M(-24.7%) |
| Dec 2001 | $52.67M(-37.0%) | $11.13M(-15.8%) |
| Sep 2001 | - | $13.21M(-7.5%) |
| Jun 2001 | - | $14.29M(+6.8%) |
| Mar 2001 | - | $13.38M(-58.0%) |
| Dec 2000 | $83.55M(+133.4%) | $31.86M(+194.3%) |
| Sep 2000 | - | $10.83M(-65.1%) |
| Jun 2000 | - | $31.07M(+217.1%) |
| Mar 2000 | - | $9.80M(+1.0%) |
| Dec 1999 | $35.80M(+167.2%) | $9.70M(+34.7%) |
| Sep 1999 | - | $7.20M(+14.3%) |
| Jun 1999 | - | $6.30M(-49.2%) |
| Mar 1999 | - | $12.40M |
| Dec 1998 | $13.40M | - |
FAQ
- What is United Therapeutics annual total expenses?
- What is the all time high annual total expenses for United Therapeutics?
- What is United Therapeutics annual total expenses year-on-year change?
- What is United Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for United Therapeutics?
- What is United Therapeutics quarterly total expenses year-on-year change?
What is United Therapeutics annual total expenses?
The current annual total expenses of UTHR is $1.43B
What is the all time high annual total expenses for United Therapeutics?
United Therapeutics all-time high annual total expenses is $1.64B
What is United Therapeutics annual total expenses year-on-year change?
Over the past year, UTHR annual total expenses has changed by +$286.70M (+25.09%)
What is United Therapeutics quarterly total expenses?
The current quarterly total expenses of UTHR is $411.60M
What is the all time high quarterly total expenses for United Therapeutics?
United Therapeutics all-time high quarterly total expenses is $1.02B
What is United Therapeutics quarterly total expenses year-on-year change?
Over the past year, UTHR quarterly total expenses has changed by +$90.20M (+28.06%)